The drug treats fast-growing, deadly brain cancers with no effective treatment.
Biotech company acquires OMRF brain cancer drug
Agreement will expand clinical trials of glioblastoma drug
Biomarkers help doctors decide how to treat brain cancers
OMRF’s biomarker discoveries could bring new therapies for beating gliomas.
OMRF brain cancer drug enters clinical trials at OU cancer center
OMRF, Stephenson Cancer Center begin tests of experimental compound
Attacking cancer on multiple fronts
Cutting off avenues for growth is key to killing tumors.
For many cancers, the odds of survival now are better than ever and going up.